Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
Eurotech enters multiple contracts with DynaVox for Catalyst embedded computers

Eurotech enters multiple contracts with DynaVox for Catalyst embedded computers

Traumatic brain injuries during war increase risk of epilepsy even decades later

Traumatic brain injuries during war increase risk of epilepsy even decades later

Thymosin beta 4 improves neurological functional outcome after embolic stroke: Researchers

Thymosin beta 4 improves neurological functional outcome after embolic stroke: Researchers

VCU Medical Center ranked in 2010-2011 Best Hospitals

VCU Medical Center ranked in 2010-2011 Best Hospitals

Serum BNP do not increase in pediatric trauma patients with serious head injuries: Report

Serum BNP do not increase in pediatric trauma patients with serious head injuries: Report

Severe trauma to head and spine from ATV accidents on the rise: Research

Severe trauma to head and spine from ATV accidents on the rise: Research

Experts to discuss latest advancements in neurological disorders at Neurorehabilitation Symposium

Experts to discuss latest advancements in neurological disorders at Neurorehabilitation Symposium

Oxycyte PFCE decreases mortality after onset of decompression sickness in porcine model study

Oxycyte PFCE decreases mortality after onset of decompression sickness in porcine model study

Study examines long-term effect of TBI on women's reproductive health

Study examines long-term effect of TBI on women's reproductive health

Neuralstem announces completion of $10 million registered direct offering

Neuralstem announces completion of $10 million registered direct offering

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

New brain-to-computer chip technology revolutionizes neurological therapy

New brain-to-computer chip technology revolutionizes neurological therapy

Oxygen' common stock to begin trading on Swiss SIX Exchange

Oxygen' common stock to begin trading on Swiss SIX Exchange

New center opens for vets with traumatic brain injuries and psychological issues

New center opens for vets with traumatic brain injuries and psychological issues

National Intrepid Center of Excellence to treat veterans with traumatic brain injury

National Intrepid Center of Excellence to treat veterans with traumatic brain injury

Athersys, CSCRM and CWRU receive $1M to advance MultiStem therapy for SCI

Athersys, CSCRM and CWRU receive $1M to advance MultiStem therapy for SCI

Healthcare technology innovation projects to receive $3M in CIMIT medical research grants

Healthcare technology innovation projects to receive $3M in CIMIT medical research grants

Antibody treatment could significantly improve lives following spinal cord injury: Researchers

Antibody treatment could significantly improve lives following spinal cord injury: Researchers

Sinapis initiates dosing in Phase I trial of intravenous infusion of methamphetamine

Sinapis initiates dosing in Phase I trial of intravenous infusion of methamphetamine

Oxygen Biotherapeutics' common stock approved for secondary listing on SIX Swiss Exchange

Oxygen Biotherapeutics' common stock approved for secondary listing on SIX Swiss Exchange

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.